$1.71
-0.09-5.00%
At close: -
$1.71
-0.000100-0.01%
After Hours: 4:07 PM EDT
Comments
Loading...
Perspective Therapeutics Insider Trading Activity | AMEX:CATX | Benzinga
Track the latest Perspective Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Perspective Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Perspective Therapeutics Inc Insiders Doing?
At Perspective Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 143.82K shares for a total value of $316.77K.
Notable Recent Insider Buys and Sales
- On April 1, 2025, Robert F. Williamson III, the company's - purchased 60.34K shares for $2.19 each.
- On April 1, 2025, Juan Graham, the company's CHIEF FINANCIAL OFFICER purchased 33.33K shares for $2.25 each.
- On April 1, 2025, Johan (Thijs) Spoor, the company's CHIEF EXECUTIVE OFFICER purchased 26.68K shares for $2.24 each.
Ownership Statistics for Perspective Therapeutics Inc
Shares Outstanding
74.052M
Insider Shares Owned
3.924M
Insider Percentage Owned
5.30%
Institutional Shares Held
24.580M
Institutional Percentage Held
33.0%
| Apr 01, 2025 | Johan (Thijs) Spoor | CHIEF EXECUTIVE OFFICER | 26.68K | $2.24 | $59.67K | BUY | ∞ | 9.30K | Mar 28 | View |
| Apr 01, 2025 | Robert F. Williamson III | — | 60.34K | $2.19 | $132.15K | BUY | 123.11% | 109.35K | Mar 28 - Mar 31 | View |
| Apr 01, 2025 | Juan Graham | CHIEF FINANCIAL OFFICER | 33.33K | $2.25 | $74.95K | BUY | 1649.33% | 35.35K | Mar 28 | View |
| Apr 01, 2025 | Lori A Woods | — | 23.48K | $2.13 | $50.00K | BUY | 14.25% | 188.27K | Mar 31 | View |
| Dec 06, 2024 | Heidi Henson | — | 25.98K | $3.85 | $100.00K | BUY | ∞ | 25.98K | Dec 04 | View |
| Dec 04, 2024 | Johan (Thijs) Spoor | CEO | 8.00K | $3.77 | $30.13K | BUY | 27.34% | 37.26K | Dec 04 | View |
| Nov 27, 2024 | Robert Williamson | — | 6.27K | $3.64 | $22.81K | BUY | 1.47% | 433.72K | Nov 25 | View |
| Nov 27, 2024 | Jonathan Hunt | CHIEF FINANCIAL OFFICER | 12.83K | $3.82 | $48.97K | BUY | 35.66% | 48.80K | Nov 25 | View |
| Nov 26, 2024 | Johan (Thijs) Spoor | CEO | 26.50K | $3.79 | $100.47K | BUY | 52.89% | 76.60K | Nov 25 | View |
| Jun 18, 2024 | Jonathan Hunt | CHIEF FINANCIAL OFFICER | 1.80K | $9.81 | $17.67K | BUY | 5.27% | 35.97K | Jun 17 | View |
| Jun 18, 2024 | Lori Woods | — | 4.59K | $10.90 | $49.99K | BUY | 2.86% | 164.79K | Jun 14 | View |
| Jun 13, 2024 | Johan (Thijs) Spoor | CEO | 100.00K | $1.17 | $117.43K | BUY | 210.21% | 147.57K | Jun 13 | View |
| Jun 04, 2024 | Lori A Woods | — | 34.25K | $1.46 | $49.99K | BUY | 2.25% | 1.55M | Jun 03 | View |
| Jun 03, 2024 | Jonathan Hunt | CHIEF FINANCIAL OFFICER | 25.01K | $1.40 | $35.01K | BUY | 7.90% | 341.72K | May 31 | View |
| Jun 03, 2024 | Robert F. Williamson III | — | 55.00K | $1.38 | $75.90K | BUY | 14.77% | 427.45K | May 31 | View |
| May 30, 2024 | Robert F. Williamson III | — | 30.03K | $1.33 | $40.01K | BUY | 8.77% | 372.45K | May 29 | View |
| Mar 08, 2024 | Lantheus Alpha Therapy LLCLantheus Holdings Inc | — | 60.43M | $0.95 | $57.41M | BUY | 107.26% | 116.77M | Mar 06 | View |
| Feb 01, 2024 | Robert F. Williamson III | DIRECTOR | 127.21K | $0.71 | $90.71K | BUY | 59.11% | 342.42K | Jan 30 | View |
| Jan 30, 2024 | Robert F. Williamson III | DIRECTOR | 135.88K | $0.58 | $78.47K | BUY | 171.26% | 215.22K | Jan 26 - Jan 29 | View |
| Jan 26, 2024 | Markus Puhlmann | CHIEF MEDICAL OFFICER | 280.00K | $0.50 | $139.89K | BUY | 25.56% | 1.38M | Jan 24 | View |
| Jan 26, 2024 | Robert F. Williamson III | DIRECTOR | 52.00K | $0.49 | $25.48K | BUY | 190.16% | 79.34K | Jan 24 - Jan 25 | View |
| Dec 26, 2023 | Robert F. Williamson III | DIRECTOR | 3.66K | $0.33 | $1.20K | BUY | 15.47% | 27.34K | Dec 21 | View |
| Dec 19, 2023 | Jonathan Hunt | CHIEF FINANCIAL OFFICER | 125.00K | $0.26 | $32.34K | BUY | 65.20% | 316.71K | Dec 18 | View |
| Dec 19, 2023 | Robert F. Williamson III | DIRECTOR | 23.68K | $0.29 | $6.98K | BUY | ∞ | 23.68K | Dec 18 - Dec 19 | View |
| Dec 19, 2023 | Markus Puhlmann | CHIEF MEDICAL OFFICER | 595.42K | $0.32 | $188.74K | BUY | 119.08% | 1.10M | Dec 15 - Dec 19 | View |
| Dec 18, 2023 | Lori A Woods | DIRECTOR | 185.20K | $0.27 | $49.99K | BUY | 13.39% | 1.57M | Dec 14 - Dec 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.